Not finding it? Sign in to also search OpenAlex live.
-
Quality Tolerance Limits’ Place in the Quality Management System and Link to the Statistical Trial Design: Case Studies and Recommendations from Early Adopters2023 Therapeutic Innovation & Regulatory Science article Mathematics Statistical Methods in Clinical Trials Open access
Marion Wolfs, Łukasz Bojarski, Lynne Cesario, Marcin Makowski, Linda B. Sullivan
8citations -
Practical consequences of the European union-AI act for anatomic pathology laboratories a European society of pathology and European society of digital and integrative pathology commissioned expert opinion paper2025 Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin article Medicine Artificial Intelligence in Healthcare and Education Open access
Frederik Deman, Sofia Palmieri, Glenn Broeckx, Thomas Van Den Berghe, Inti Zlobec, Peter Schirmacher, +9 more
11citations -
Establishing a Data Quality Baseline in the AKTIN Emergency Department Data Registry – A Secondary Use Perspective2022 Studies in health technology and informatics book-chapter Decision Sciences Data Quality and Management Open access
Lucas Triefenbach, Ronny Otto, Jonas Bienzeisler, Alexander Kombeiz, Saskia Ehrentreich, Rainer Röhrig, +1 more
2citations -
Poster Session I - A36 OPTIMIZING AND STANDARDIZING DONOR SCREENING FOR FECAL MICROBIOTA TRANSPLANTATION: A DELPHI REVIEW2026 Journal of the Canadian Association of Gastroenterology article Medicine Clostridium difficile and Clostridium perfringens research Open access
C S Liu, Blair Merrick, Zahra Salem Taboun, Benjamin Harvey Mullish, Ed J. Kuijper, D Kao
0citations -
Individualized treatment effect was predicted best by modeling baseline risk in interaction with treatment assignment2022 arXiv (Cornell University) preprint Mathematics Statistical Methods in Clinical Trials Open access
Alexandros Rekkas, Peter R. Rijnbeek, David M. Kent, Ewout Willem Steyerberg, David V. Klaveren
0citations -
Improving cardiovascular population risk in primary care: protocol for the PROSPERA cluster-randomised controlled trial of a complex multilevel intervention
Vera A. M. C. Bongaerts, Rimke Cathelijne Vos, Steven H J Hageman, Ken Redekop, Jannick A N Dorresteijn, Mattijs Everard Numans, +1 more
0citations -
Nonclinical toxicity study duration in AAV gene therapy development: Evidence from industry survey supports adequacy of short-term assessments2025 Molecular Therapy — Methods & Clinical Development article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access
Basel T. Assaf, Shawn Jay Berens, Brian Lauritzen, Francis Fonyuy Tukov, Cristina Bertinetti‐Lapatki, Manuela Braun, +1 more
3citations -
Predictive approaches to heterogeneous treatment effects: a scoping review2020 BMC Medical Research Methodology article Mathematics Statistical Methods in Clinical Trials Open access
Alexandros Rekkas, Jessica K. Paulus, Gowri Raman, John B. Wong, Ewout Willem Steyerberg, Peter R. Rijnbeek, +2 more
88citations